<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TECHNION-ISRAEL_Assay_Model skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TECHNION-ISRAEL/Assay Model</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>navbar</TITLE></P><DIV class="container-fluid" style="margin-top:0px;"><DIV class="row"><DIV class="col-md-12"><NAV class="navbar navbar-inverse navbar-fixed-top " style=" z-index:800; position:fixed; margin:auto; width: 1180px ;"><DIV class="dropdown" style="padding-left: 100px;"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"><A href="https://2017.igem.org/Team:TECHNION-ISRAEL"> project </A></BUTTON><UL class="dropdown-menu" style=" margin: 0px;  left:78px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Description"> description </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Diseases"> Diseases &amp; Epitopes </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Design"><SPAN id="T">T</SPAN>ri-Display </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/delay_mechanism"><SPAN id="T">  T</SPAN>iming </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/kill_switch"><SPAN id="T">T</SPAN>erminate</A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Demonstrate"><SPAN id="T"> T</SPAN>olerance Assay </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"> wet lab 
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/cell_lines"> cell lines </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Results"> results </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/hpc7"> hpc-7 results </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Notebook"> notebook </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Experiments"> protocols </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/InterLab"> interlab </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Parts"> parts </A></BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Parts"> parts </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Basic_Part"> basic part </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Composite_Part"> composite part </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Part_Collection"> part collection </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Improve">	 improvement </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown" style="width: auto"> human practices 
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 18px; width: 170px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Silver"> HP silver </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Engagement"> Education &amp; Public Engagement </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Gold_Integrated"> integrated HP </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/ethics"> ethics </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"> judging
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px "><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Safety"> safety </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Collaborations"> collaboration </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Achievements"> achievements </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Model"> modelling </A></LI></UL></DIV><DIV class="dropdown" style="padding-right: 100px;"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown">team
							</BUTTON><UL class="dropdown-menu" style=" margin: 0px;  left: 2px;"><LI><A href=" https://2017.igem.org/Team:TECHNION-ISRAEL/Team"> members </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Attributions"> attributions </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/gallery"> gallery </A></LI></UL></DIV></NAV></DIV></DIV></DIV><P><TITLE>Our Model</TITLE></P><DIV class="container-fluid"><DIV class="row"><H2>Tolerance Assay Model  </H2><DIV class="col-md-2"><DIV class="side"><UL class="sidelist hidden-sm" style="width:auto; padding-top:0px;"><LI><A class="cell" href="#Purpose"> Purpose of our model  </A></LI><LI><A class="cell" href="#Does">What our model does </A></LI><LI><A class="cell" href="#Assumptions">Assumptions </A></LI><LI><A class="cell" href="#Results">Results and Analysis </A></LI></UL></DIV></DIV><DIV class="col-md-8"><DIV class="row"><DIV class="col-md-12"><H4 id="Purpose">The purpose of our model </H4><P>
							We set out to model the interaction between our engineered model cell lines (HPC-7 /HEK293 cells presenting antigen) and an immature B cell model (WEHI-231 naturally presenting IgM). We chose to model this interaction because data and protocols for this kind of assay are scarce or non-existent. It was our goal to produce valuable information, which would be incorporated into our wet-lab experiment, in an attempt to define more concretely the necessary conditions and concentrations for our assay. 
							</P><H4 id="Does">What our model does </H4><P>
							Our model simulates receptor induced apoptosis in heterogeneous mammalian cell co-culture. Given initial conditions by the user, our model predicts the rate at which the cells within the system will die. While seemingly a simple task, due to the variable nature of cells and receptor presentation combined with non-binary signaling, the system is very complex. Determining the optimal initial concentrations of each cell line as well as the necessary transfection efficiency would require tens of experiments and weeks of work. Using our model, researchers may narrow down the ranges of the aforementioned parameters, saving valuable time and money.
							</P><H4 id="Assumptions">
							Assumptions
							</H4><OL class="model-list"><LI>The growth rate of HEK293 cells is similar to the growth rate of WEHI cells</LI><LI>WEHI-231 cells undergo apoptosis as a result of interaction with antigen presenting HEK/HPC cells</LI><LI>K<SPAN style="font-size: 11px;">apop</SPAN> &gt; K<SPAN style="font-size: 11px;">a</SPAN></LI></OL><P>
							In order to accurately model our system, we designed a kinetic model based on the following equations:
							</P></DIV></DIV><DIV class="row"><DIV class="col-md-offset-2 col-md-8"><P style="text-align: center;"><STRONG> Eq. 1</STRONG>: Chemical equations describing the system  </P><P style="text-align: center;"><STRONG> Eq. 2</STRONG>: Set of three ODEs describing the interactions within the system </P></DIV></DIV><DIV class="row"><DIV class="col-md-12"><P>
							Where:
							<UL class="model-ul"><LI> H represents our model cell lines HEK293/HPC-7</LI><LI>
							W represents the WEHI cells
							</LI><LI>
							H-W represents HEK cells bound to WEHI cells
							</LI><LI>
							K<SPAN style="font-size: 11px;">H</SPAN> is the proliferation rate constant of HEK/HPC cells
							</LI><LI><SPAN style="font-size: 27px;">ᵞ</SPAN><SPAN style="font-size: 11px;">H</SPAN> is the death rate constant of HEK/HPC cells
							</LI><LI>
							K<SPAN style="font-size: 11px;">W</SPAN> is the proliferation rate constant of WEHI cells
							</LI><LI><SPAN style="font-size: 27px;">ᵞ</SPAN><SPAN style="font-size: 11px;">W</SPAN> is the death rate constant of WEHI cells
							</LI><LI>
							K<SPAN style="font-size: 11px;">a</SPAN> is the binding rate constant for combination of HEK and WEHI to form H-W
							</LI><LI>
							K<SPAN style="font-size: 11px;">d</SPAN> is the rate constant for disassociation of H-W to form HEK and WEHI
							</LI><LI>
							K<SPAN style="font-size: 11px;">apop</SPAN> is the rate constant for the apoptosis of WEHI cells as a result of binding HEK cells 
							</LI></UL></P><P>
							The equations were solved by MATLAB and the simulation was done using the following values for constants and initial concentrations: 
							</P></DIV></DIV><DIV class="row"><DIV class="col-md-offset-2 col-md-8"><P style="text-align:center;"> Chart 1 – values of constants and initial concentrations </P><TABLE class="table table-list-search"><THEAD><TR><TH style="width:50%; text-align:center;">Constants and Initial Conc. </TH><TH style="width:50%; text-align:center;">Value (arbitrary units) </TH></TR></THEAD><TBODY><TR><TD>[HEK/HPC]<SPAN style="font-size: 11px;">0</SPAN></TD><TD>4</TD></TR><TR><TD>[WEHI]<SPAN style="font-size: 11px;">0</SPAN></TD><TD>6</TD></TR><TR><TD>K<SPAN style="font-size: 11px;">H</SPAN></TD><TD>1</TD></TR><TR><TD><SPAN style="font-size: 27px;">ᵞ</SPAN><SPAN style="font-size: 11px;">H</SPAN></TD><TD>0.09</TD></TR><TR><TD>K<SPAN style="font-size: 11px;">W</SPAN></TD><TD>1</TD></TR><TR><TD><SPAN style="font-size: 27px;">ᵞ</SPAN><SPAN style="font-size: 11px;">W</SPAN></TD><TD>0.01</TD></TR><TR><TD>K<SPAN style="font-size: 11px;">a</SPAN></TD><TD>2</TD></TR><TR><TD>K<SPAN style="font-size: 11px;">d</SPAN></TD><TD>0.06</TD></TR><TR><TD>K<SPAN style="font-size: 11px;">apop</SPAN></TD><TD>3</TD></TR></TBODY></TABLE></DIV></DIV><DIV class="row"><DIV class="col-md-12"><P>
						The ratios between the constants were defined based on the ratios found in relevant 
						literature
							<SUP id="cite ref-1 " class="reference"><A href="#ref1" original-title="">[1] </A></SUP><SUP id="cite ref-2 " class="reference"><A href="#ref2" original-title="">[2] </A></SUP>.  
						
						The initial concentrations were determined based on a <A target="_blank" href="https://2017.igem.org/Team:TECHNION-ISRAEL/Notebook"> co-culture experiment</A> that we conducted. In this experiment we aimed to test the viability of HEK cells that were not transfected with the assay plasmid, and thus don't induce apoptosis, and WEHI cells, in co-culture. Different ratios of [WEHI]:[HEK/HPC] cells were tested and the optimal ratio was found to be 6:4 for [WEHI]:[HEK/HPC] respectively. 
						</P><H4 id="Results">Results and Analysis </H4></DIV></DIV><DIV class="row"><DIV class="col-md-offset-1 col-md-10"><P style="text-align: center;"><STRONG> Figure 1: </STRONG> The model simulation results - when using the constants as listed in Chart 1   </P></DIV></DIV><DIV class="row"><DIV class="col-md-12"><P>
						As can be seen in <STRONG>figure 1</STRONG>, our model is in line with our expectations. We can see that the WEHI cells undergo apoptosis as a result of co-culture with the antigen displaying HEK/HPC cells, and in direct response to the increase of H-W complexes.
						
						In order to further characterize our system, we tested our model using different constants and cell ratios. We discovered that setting the value of 
						K<SPAN style="font-size: 11px;">a</SPAN>  equal to
						K<SPAN style="font-size: 11px;">H</SPAN>  yields a second behavioral regime in the model <STRONG>(figure 2)</STRONG>:

						</P></DIV></DIV><DIV class="row"><DIV class="col-md-offset-1 col-md-10"><P style="text-align: center;"><STRONG> Figure 2:</STRONG> The model simulation results when K<SPAN style="font-size: 11px;">a</SPAN>=K<SPAN style="font-size: 11px;">H</SPAN></P></DIV></DIV><DIV class="row"><DIV class="col-md-12"><P>
						For this value of K<SPAN style="font-size: 11px;">a</SPAN>, and for a wide range of smaller values, the same behavior was observed. We can conclude that when K<SPAN style="font-size: 11px;">a</SPAN> is higher than K<SPAN style="font-size: 11px;">H</SPAN>, at least 50% of HEK cells must bind WEHI cells in order to reduce the amount of WEHI cells to a negligible level.
						</P><P>
						We also found  that our model is robust and shows the same behavior for a wide range of initial concentration ratios-  a decrease in WEHI cells to near zero. For example, setting the ratio of [WEHI]:[HEK/HPC-7] to 4:6 yielded the following graph <STRONG>(figure 3)</STRONG>:
						</P></DIV></DIV><DIV class="row"><DIV class="col-md-offset-1 col-md-10"><P style="text-align: center;"><STRONG> Figure 3:</STRONG> The model simulation results for the initial concentrations [WEHI]:[HEK/HPC] ratio of 4:6  </P></DIV></DIV><DIV class="row"><DIV class="col-md-12"><P>
						As the model predicted excellent results using a [WEHI]:[HEK] ratio of 6:4, we conducted the 
						tolerance assay experiment using this ratio. Our 
						<A target="_blank" href="https://2017.igem.org/Team:TECHNION-ISRAEL/Results#Proofofconcept">Results</A> established our model’s assumptions and demonstrated a qualitatively equivalent outcome.
						</P><DIV class="references"><OL><LI id="ref1"> Rudich, S. M., et al. &quot;Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.&quot; <I>Journal of Experimental Medicine</I> 168.1 (1988): 247-266.</LI><LI id="ref2"> Molina-Peña, Rodolfo, and Mario Moisés Álvarez. &quot;A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth.&quot; <I>PloS one</I> 7.2 (2012): e26233.  </LI></OL></DIV></DIV></DIV></DIV></DIV></DIV><TITLE>My First Website</TITLE><DIV class="footer"><DIV class="container-fluid"><DIV class="row"><DIV class="col-md-offset-1 col-md-10"><DIV class="row"><DIV class="col-md-4 nopadding"><DIV class="location"><P style="text-indent:inherit; margin-top: 30px; padding-bottom:15px;color:  #ffffff; 	font-family:  'Quicksand', sans-serif; 	font-size: 14px; 	line-height:25px; 	text-align: unset;">
											
							Department of Biotechnology &amp; Food Engineering
							
							
							Technion – Israel Institute of Technology
							
							
							Haifa 32000, Israel
							</P></DIV></DIV><DIV class="col-md-offset-3 col-md-3"><DIV class="contact" style="margin-top: 20px;"><UL><P style=" text-indent:inherit; margin-top: 5px; color:  #ffffff; font-family: 'Quicksand', sans-serif;	font-size: 14px;">
									igem.technion.2017@gmail.com
									</P></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>